Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Attend a group training Schedule a 1-on-1 guided demo Watch a demo video
Ariella_200sq
Name
Ariella Chivil
Title
Patient Advocate
Bio
Ariella Chivil was diagnosed with Hodgkin lymphoma in 2010, just before her junior year of college. After completing 14 different treatment protocols, each with its own set of side effects and complications, Ariella and her doctors decided to try something new: a clinical trial of the immunotherapy nivolumab (Opdivo®). Her first scans after beginning the trial showed a marked reduction in her tumors. In May 2016, nivolumab received FDA approval for the treatment of Hodgkin lymphoma. Today, Ariella is off treatment and enjoying living and working in New York City.